60% of Revenue from Wang Yibo? YH ENT Responds: Proportion Gradually Declining

Deep News
2025/11/06

On November 6, recent reports claimed that Wang Yibo would not renew his contract with YH ENT upon expiration. Sources indicated that in 2024, YH ENT's total revenue reached 765 million yuan, with Wang Yibo—dubbed the "top cash cow"—contributing over 60%. Additional data revealed that his contribution has surged annually since 2019, rising from 16.8% in 2019 to 56.8% in 2022 and hitting the 60% mark in 2024.

When asked whether Wang Yibo's potential departure would impact the company's stock price, YH ENT's investor relations department stated, "The current stock performance remains stable, with recent gains." They added, "His (Wang Yibo) revenue share within the company is gradually decreasing, and his contract was originally set to expire next year. Please await our official announcement at that time."

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10